A maternal RSV vaccine to protect infants is one step closer to FDA approval
The candidate vaccine created by Pfizer would be approved for pregnant people to help prevent severe disease in infants from birth through 6 months.
from USATODAY - News Top Stories https://ift.tt/3q0ExVf
The candidate vaccine created by Pfizer would be approved for pregnant people to help prevent severe disease in infants from birth through 6 months.
Post a Comment